期刊文献+

加替沙星在家兔体内的代谢动力学研究 被引量:1

Study on the Pharmacodynamics of Gatifloxacin in Rabbits
下载PDF
导出
摘要 [目的]分析加替沙星在家兔体内的药代动力学过程。[方法]家兔口服5、10和20mg/kg加替沙星后于0.25、0.50、1.00、2.00、4.00、8.00、12.00和24.00h分别取静脉血,应用毛细管区带电泳-二极管阵列检测法测定血药浓度并计算代谢动力学参数。家兔口服10mg/kg加替沙星后于0.25、0.50、1.00、2.00和4.00h分别测定心、肺、肌肉等组织中的药物浓度。[结果]加替沙星在0.05~5.00μg/ml范围内具有良好线性关系,最低检测限为0.05μg/ml,在家兔血液代谢动力学过程符合一室模型。5、10和20mg/kg剂量组主要动力学参数如下:峰浓度(cmax)分别为2.28、3.35和7.93μg/ml;达峰时间(Tmax)分别为1.36、1.83和1.69h;吸收半衰期(t1/2Ka)分别为0.39、0.51和0.42h;消除半衰期(t1/2 Ke)分别为5.63、6.07和6.81h;药时曲线下面积(AUC)分别为21.67、33.59和97.07(μg·h)/ml。加替沙星被家兔摄入后,迅速分布于各组织中。[结论]加替沙星在家兔体内吸收迅速,消除半衰期长,组织分布广泛,是一种值得推广的新型氟喹诺酮类抗生素。 [ Objective ] The study aimed to analyze the pharmaeodynamics process of gatifloxacin in rabbits. [ Method ] Following the oral ad- ministration of a single dose of 5,10 and 20 mg/kg gatifloxacin to rabbits, their vein blood was selected resp. at 0. 25 ,0. 50,1. 00,2.00,4.00, 8.00,12.00 and 24.00 h after administration, and the gatifloxacin concn, in the plasma were determined by coupling capillary Zone Electrophoresis with Diode Array Detection (CZE-DAD) , resp. and then the pharmacodynamies parameters were calculated. After the oral administration of a single dose of 10 mg/kg gatifloxacin to the rabbits,the gatifloxaein eoncn, in different tissues such as heart,lung,muscle were de- termined resp. at O. 25,0.50,1.00,2.00,4. O0 h after administration. [ Result] The gatifloxacin had good linear relation over the range from 0.05 to 5.00μg/ml,with a detection limit of 0.05 μg/ml. The pharmacodynamics process of rabbits fitted to one compartment model. The main kinetic parameters for the dose groups at 5,10, and 20 mg/kg were follows : Cmox were 2.28,3.35 and 7.93μg/ml resp. ; Tmax were 1.36, 1.83 and 1.69 h respe. ; t1/2Ka were 0.39,0.51 and 0.42 h resp. ; t1/2Ke were 5.63,6.07 and 6.81 h resp. ; AUC were 21.67,33.59 and 97.07 (μg·h)/ml resp. The gatifloxaein fed to rabbits was rapidly and extensively distributed to all tissues. [ Conclusion] The gatifloxaein was rapidly absorbed in rabbits ,with a longer t~/2Ke and extensive distribution ,which is a new and effective fluoro-guinolone antibiotic that was worth to be extended.
出处 《安徽农业科学》 CAS 北大核心 2009年第22期10530-10532,共3页 Journal of Anhui Agricultural Sciences
基金 国家自然科学基金项目(20565001) 广西科学基金项目(0236014)
关键词 加替沙星 家兔 药代动力学 毛细管区带电泳-二极管阵列检测 Gatifloxaein Rabbits Pharamacodynamics CZE-DAD
  • 相关文献

参考文献5

二级参考文献39

  • 1副岛林造.Gatifloxacin(GFLX)の概要[J].日本化学疗法学会杂志,1999,47(2):1-1.
  • 2柴孝也.健康成人におけゐgatifloxacinの体内动态に及ほす水酸化ろルミニウム及びシメジンの影响[J].日本化学疗法学会杂志,1999,47(S-2):218.
  • 3柴孝也.健康成人におけゐgatifloxacinの体内动态に及ぼす铁剂の并用,びに绿茶またば牛乳によゐ服药の影响[J].日本化学疗法学会杂志,1999,47(S-2):224.
  • 4(文)藤笃,中山一朗,大道光秀,他.内科领域感染症に对すゐgatifloxacin の前期第Ⅱ相临床试验[J].日本化学疗法学会杂志,1999,47(S-2):260.
  • 5(文)藤笃,大道光秀,荒川正昭,他.呼吸器感染症に对すゐgatifloxacinの后期第Ⅱ相临床试验[J].日本化学疗法学会杂志,1999,47(S-2):277.
  • 6河田幸道,熊本悦明,折笠精一,他.泌尿器科领域感染症に对すゐgatifloxacinの前期第Ⅱ相临床试验[J].日本化学疗法学会杂志,1999,47(S-2):292.
  • 7河田幸道,熊本悦明,折笠精一,他.泌尿器科领域感染症に对すゐgatifloxacin の后期第Ⅱ相临床试验[J].日本化学疗法学会杂志,1999,47(S-2):308.
  • 8由良二郎,岩井重富,中村阳一,他.外科领域におけゐgatifloxacinの基础的,临床的检讨[J].日本化学疗法学会杂志,1999,47(S-2):323.
  • 9荒田次郎,神崎宽子,石桥康正,他.皮肤科领域におけゐgatifloxacinの基础的,临床的检讨[J].日本化学疗法学会杂志,1999,47(S-2):338.
  • 10松田静治,千村哲朗,平山寿雄,他.产妇人科领域におけゐgatifloxacinの基础的,临床的检讨[J].日本化学疗法学会杂志,1999,47(S-2):351.

共引文献186

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部